LAM IPM wound gel
This article was originally published in The Gray Sheet
Executive Summary
LAM Pharmaceutical's sodium hyaluronate product, 510(k) cleared April 15, has an 88% effectiveness rate "in creating the necessary environment for wound healing of refractory (hard to heal) leg and foot ulcers," the firm says. The Lewiston, New York firm will launch the gel on June 3. The device is indicated for over-the-counter use on minor abrasions and cuts and for use under the supervision of a health professional for exuding wounds such as leg, pressure and diabetic ulcers...